The translational potential of epigenetic modulatory bioactive phytochemicals as adjuvant therapy against cancer
International Review of Cell and Molecular Biology · 2025
DOI: 10.1016/bs.ircmb.2024.09.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Review of Cell and Molecular Biology, 2025. Verfasst von Priya Mondal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, CSIR-Central Food Technological Research Institute, Mysore, India; Academy of Scientific and Innovative Research (AcSIR),…. Hauptthemen laut MEDLINE: Neoplasms, Phytochemicals, Epigenesis, Genetic, Translational Research, Biomedical. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 215 Literaturangaben.
Abstract (Originalsprache)
In preclinical studies, bioactive phytochemicals have shown enormous potential therapeutic efficacy against various human malignancies. These natural compounds have been shown to possess an inherent potential to alter the molecular signaling pathways and epigenetic modulatory activity involved in multiple physiological functions. Recently, epigenetic therapy has emerged as an important therapeutic modality due to the reversible nature of epigenetic alterations. To date, epigenetic modulatory compounds, for example, DNA methyltransferase inhibitors 5-azacytidine and 5'-deoxyazacytidine, as well as histone deacetylase inhibitors Vorinostat, Romidepsin, and Belinostat (PXD101), have been clinically approved by the FDA for the treatment of patients of leukemia and myelodysplastic syndrome. However, these synthetic epigenetic inhibitors are not as effective against many of the solid tumors. Therefore, the epigenetic modulatory phytochemicals provide new hope for improving the treatment modality as neoadjuvant and adjuvant therapy. It has been established that targeting more than one protein in the transformed cells simultaneously, that is, the multi-targeted therapeutic approach, might invoke a better therapeutic response. Therefore, here, we are compiling diverse evidences of the translational potential of novel combinatorial approaches utilizing the epigenetic modulatory phytochemicals with available therapeutics in the course of cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, CSIR-Central Food Technological Research Institute, Mysore, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
- Department of Biochemistry, CSIR-Central Food Technological Research Institute, Mysore, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India. Electronic address: syedmusthapa@gmail.com.
Zitieren
APA
Mondal, P., Jayaprakash, G., & Meeran, S. M. (2025). The translational potential of epigenetic modulatory bioactive phytochemicals as adjuvant therapy against cancer. International Review of Cell and Molecular Biology. https://doi.org/10.1016/bs.ircmb.2024.09.003
Vancouver
Mondal P, Jayaprakash G, Meeran SM. The translational potential of epigenetic modulatory bioactive phytochemicals as adjuvant therapy against cancer. International Review of Cell and Molecular Biology. 2025. doi:10.1016/bs.ircmb.2024.09.003
BibTeX
@article{Mondal2025,
author = {Mondal, Priya and Jayaprakash, Gowthami and Meeran, Syed Musthapa},
title = {The translational potential of epigenetic modulatory bioactive phytochemicals as adjuvant therapy against cancer},
journal = {International Review of Cell and Molecular Biology},
year = {2025},
doi = {10.1016/bs.ircmb.2024.09.003}
}
EUVIMED